EV/EBITDA:
114.49-1.11(-0.96%)Summary
- As of today (September 16, 2025), PTGX EV/EBITDA is 114.49, with a fall of -1.11 (-0.96%) during the most recent trading session on September 15, 2025.
- Over the past year, PTGX EV/EBITDA has increased by +100.24 (+703.44%).
- PTGX EV/EBITDA is now -5.82% below its all-time high of 121.56.
Performance
PTGX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
PTGX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.0% | -1.0% | -0.8% |
| 1 m1 month | +4.9% | +4.9% | +4.1% |
| 3 m3 months | +17.7% | +4.8% | +3.6% |
| 6 m6 months | +881.1% | +3.0% | +6.6% |
| ytdytd | +1402.5% | +57.7% | +51.2% |
| 1 y1 year | +703.4% | +38.6% | +24.2% |
| 5 y5 years | +1410.0% | +416.3% | +169.5% |
PTGX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | 121.56 | -5.8% | 109.06 | +5.0% |
| 3 m | 3-month | 121.56 | -5.8% | 91.07 | +25.7% |
| 6 m | 6-month | 121.56 | -5.8% | 10.24 | +1018.1% |
| 1 y | 1-year | 121.56 | -5.8% | 6.83 | +1576.3% |
| 3 y | 3-year | 121.56 | -5.8% | -16.97 | +774.7% |
| 5 y | 5-year | 121.56 | -5.8% | -27.68 | +513.6% |
| alltime | all time | 121.56 | -5.8% | -27.68 | +513.6% |
PTGX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 114.49(+1402.5%) |
| 2024 | 7.62(-170.0%) |
| 2023 | -10.88(+357.1%) |
| 2022 | -2.38(-77.7%) |
| 2021 | -10.69(+13.0%) |
| Date | Value |
|---|---|
| 2020 | -9.46(+836.6%) |
| 2019 | -1.01(+46.4%) |
| 2018 | -0.69(-91.4%) |
| 2017 | -8.06(-10.1%) |
| 2016 | -8.97 |
FAQ
- What is Protagonist Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Protagonist Therapeutics, Inc.?
- What is PTGX EV/EBITDA year-to-date change?
- What is Protagonist Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Protagonist Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of PTGX is 114.49
What is the all time high EV/EBITDA for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high EV/EBITDA is 121.56
What is PTGX EV/EBITDA year-to-date change?
Protagonist Therapeutics, Inc. EV/EBITDA has changed by +106.87 (+1402.49%) since the beginning of the year
What is Protagonist Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, PTGX EV/EBITDA has changed by +100.24 (+703.44%)